Published in Biotech Business Week, November 29th, 2004
GenVec reported higher revenues and a lower net loss for the third quarter and first 9 months of 2004 compared with the same periods last year. GenVec reported a net loss of $4.8 million or $0.09 per share on revenues of $2.9 million for the quarter ended September 30, 2004 compared to a net loss of $4.9 million or $0.14 per share on revenues of $2.4 million in the comparable quarter of 2003.
For the 9 months ended September 30, 2004, the company reported a net loss of $15.2 million or $0.28 per share on revenues of $8.8 million compared to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.